This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

July 2 Premarket Briefing: 10 Things You Should Know

Here are 10 things you should know for Wednesday, July 2:

1. -- U.S. stock futures were rising on greater manufacturing activity in the U.S. and China and as the Dow Jones Industrial Average storms toward 17,000.

European and Asian stocks rose on Tuesday. In Tokyo, the Nikkei 225 index gained 0.3%

2. -- The economic calendar in the U.S. on Wednesday includes the ADP National Employment Report for June at 8:15 a.m. EDT, and factory orders for May at 10 a.m.

3. -- U.S. stocks on Tuesday rose with the Dow moving within reach of the historic 17,000-level and the S&P 500 blazing a new intraday record high, both energized by data from Detroit carmakers and signs of a Chinese economy clunking back into gear.

The Dow spiked more than 1%, around 2 points short of 17,000, on Tuesday afternoon before settling 0.77% higher at 16,956.07. 

Likewise, the S&P 500 jumped to an intraday record high of 1,978.58 earlier in Tuesday's session but receded to 1,973.32, though still up 0.67%. The Nasdaq surged 1.14% to 4,458.65.

4. -- Jamie Dimon, CEO of JPMorgan Chase (JPM - Get Report), said he has throat cancer.

"I wanted to let you know that I have just been diagnosed with throat cancer," Dimon said in memo sent to employees and shareholders. " The good news is that the prognosis from my doctors is excellent, the cancer was caught quickly, and my condition is curable. Following thorough tests that included a CAT scan, PET scan and a biopsy, the cancer is confined to the original site and the adjacent lymph nodes on the right side of my neck. Importantly, there is no evidence of cancer elsewhere in my body."

Dimon, 58 years old, said he plans to remain on the job and be actively involved in key decisions at the bank while undergoing radiation and chemotherapy treatment. The eight-week treatment will begin soon at Memorial Sloan Kettering Hospital in New York.

"While the treatment will curtail my travel during this period, I have been advised that I will be able to continue to be actively involved in our business, and we will continue to run the company as normal," Dimon said.

5. -- Fidelity Investments told investors outside the U.S. they can't buy mutual funds after July 31.

Fidelity informed about 60,000 customers, or about 0.3% of account holders, of the change in a letter, Stephen Austin, a spokesman, told Bloomberg. The clients won't be forced to sell existing holdings and will still be allowed to reinvest dividends in their funds.

The announcement reflects "a continually evolving global regulatory environment and is not in response to any specific issue, regulatory or otherwise," Austin told Bloomberg.

6. -- Roche subsidiary Genentech agreed to purchase U.S. biotechnology firm Seragon Pharmaceuticals for up to $1.725 billion in cash and contingency payments.

Switzerland's Roche, the world's biggest manufacturer of cancer drugs, said the deal will give Genentech rights to Seragon's portfolio of oral drugs under development to treat certain kinds of breast cancer.

The acquisition is for $725 million in cash and up to $1 billion in payments contingent on certain "milestones," Roche said.

7. -- Google (GOOG - Get Report) reached a deal to acquire Songza, a service that creates soundtracks tailored for people's changing moods.

Financial terms of the deal announced Tuesday were not disclosed. That means the price is considered to be too small to affect Google, which ended March with $59 billion in cash.

8. -- Constellation Brands (STZ), which sells wine, spirits and beer, is expected by analysts on Wednesday to report fiscal first-quarter earnings of 93 cents a share on revenue of $1.43 billion.

9. -- Anthony Noto, the ex-Goldman Sachs investment banker who led Twitter's (TWTR) initial public offering, is now joining the micro-blogging site as its chief financial officer.

Noto's move comes about six months after Twitter's IPO, and roughly a month after he left Goldman for tech-oriented hedge fund Coatue Management.

Twitter's appointment of Noto as financial chief looks like a move at rebuilding the company's' upper ranks after some big recent departures. Mike Gupta, Twitter's current CFO, will step down from the role to become Twitter's senior vice president of strategic investments.

10. -- One bidder won all of the nearly 30,000 Bitcoins auctioned on Friday by the United States Marshals Service.

"The U.S. Marshals Bitcoin auction resulted in one winning bidder," said Marshals Service spokeswoman Lynzey Donahue. "The transfer of the Bitcoins to the winner was completed (Tuesday)."

The Bitcoins were seized from the now-defunct market Silk Road. 

While the actual price of the winning bid isn't known, the cache sold on June 30 was worth about $19 million at current exchange prices, according to Bloomberg.

Why General Electric Stock Can Still Shock Investors After Alstom 

How GM Could Spin Off a $400 Billion Business  

GoPro's Future Is Foggy Despite Picture-Perfect IPO

-- Written by Joseph Woelfel

To contact the writer of this article, click here:Joseph Woelfel

To submit a news tip, send an email

Follow @josephwoe58

Copyright 2014 Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed. AP contributed to this report.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
GOOG $693.01 0.00%
JPM $63.20 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%
TSLA $240.76 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs